MINIMAL RESIDUAL DISEASE IN FOLLOW-UP SAMPLES OF PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT - IS THERE AN IMPACT ON THE CLINICAL OUTCOME
M. Moos et al., MINIMAL RESIDUAL DISEASE IN FOLLOW-UP SAMPLES OF PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT - IS THERE AN IMPACT ON THE CLINICAL OUTCOME, Blood, 88(10), 1996, pp. 881-881